Here we show that a knock-in reporter for the stem cell gene Musashi 2 (Msi2)18–20 can serve as a platform to define functional heterogeneity in hematological malignancies, and effectively identify LSCs in both blast crisis chronic myeloid leukemia (bcCML) and de novo AML. This evidence concerns the gene MSI2 and acute myeloid leukemia.